![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Rakshit Pharmaceuticals Limited Vishakhapatnam In, based in India, is a pharmaceutical company.
One of their significant offerings is Pantoprazole sodium sesquihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2014-060 - Rev 03
This Chemical Type CEP, issued on March 01, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2296 associated with this CEP further emphasizes